The Covid-19 crisis has a far-reaching impact on economies and societies around the globe. The existence of many companies is under acute threat, and executives have to weigh the interests of different stakeholders when deciding how to best mitigate losses and secure going concern.
One month ago, markets finally took note of COVID-19 and its critical impact on the global economy. Our Healthcare Investment Team recently published a “Thoughts from the street” piece that provides more details about SARSCoV- 2 treatment developments.
As the world grapples with the outbreak of SARS-CoV-2 and people across the world experience dramatic cuts to their freedom of movement, the healthcare sector is racing to find solutions to tackle the current pandemic. How quickly could treatments for COVID-19 realistically become available?